Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models.

Source:http://linkedlifedata.com/resource/pubmed/id/20038106

J. Med. Chem. 2010 Feb 11 53 3 1023-37

Download in:

View as

General Info

PMID
20038106